Kelly Jared
SEC insider (Form 3/4/5 filer). CIK 0002103581. Chief Executive Officer at ONCOLYTICS BIOTECH INC (ONCY). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in SAN DIEGO, CA.
Companies Kelly Jared has filed insider reports for
- ONCOLYTICS BIOTECH INC (ONCY): Director, Officer, Chief Executive Officer
Kelly Jared
CIK: 0002103581
Transaction Breakdown
Open Market Buys (P)3 (75.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ONCY
ONCOLYTICS BIOTECH INC
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 1, 2026ONCY
ONCOLYTICS BIOTECH INC
AwardDirectStock Option
755K shares- - Mar 12, 2026ONCY
ONCOLYTICS BIOTECH INC
PurchaseDirect5.1K shares at avg. $0.96$5K - Feb 12, 2026ONCY
ONCOLYTICS BIOTECH INC
PurchaseDirect29.5K shares at avg. $0.84$25K - Feb 11, 2026ONCY
ONCOLYTICS BIOTECH INC
PurchaseDirect5.6K shares at avg. $0.84$5K
1-4 of 4 transactions